Skip to main content

Fordyce Marshall's Form 4 filing

Vera Therapeutics, Inc. (VERA) · filed Sep 27, 2024

Accession no.
0001415889-24-024033
Filed
Sep 27, 2024
Trade date
Sep 25, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 22 non-derivative transactions and 5 derivative transactions. Open-market sales total $1.06M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Fordyce MarshallCIK 0001859453Director, Officer (PRESIDENT AND CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 25, 2024Class A Common StockMOption exerciseAcquired+8,643$2.90+$25,064.7316,615Direct
Sep 25, 2024Class A Common StockSSaleDisposed−8,643$45.43−$392,651.49307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+4,817$2.90+$13,969.3312,789Direct
Sep 25, 2024Class A Common StockSSaleDisposed−4,817$46.62−$224,568.54307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+2,165$2.90+$6,278.5310,137Direct
Sep 25, 2024Class A Common StockSSaleDisposed−2,165$47.06−$101,884.9307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+975$2.90+$2,827.5308,947Direct
Sep 25, 2024Class A Common StockSSaleDisposed−975$45.48−$44,343307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+900$2.90+$2,610308,872Direct
Sep 25, 2024Class A Common StockSSaleDisposed−900$46.79−$42,111307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+975$2.90+$2,827.5308,947Direct
Sep 25, 2024Class A Common StockSSaleDisposed−975$45.43−$44,294.25307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+900$2.90+$2,610308,872Direct
Sep 25, 2024Class A Common StockSSaleDisposed−900$46.79−$42,111307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+975$2.90+$2,827.5308,947Direct
Sep 25, 2024Class A Common StockSSaleDisposed−975$45.48−$44,343307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+900$2.90+$2,610308,872Direct
Sep 25, 2024Class A Common StockSSaleDisposed−900$46.79−$42,111307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+975$2.90+$2,827.5308,947Direct
Sep 25, 2024Class A Common StockSSaleDisposed−975$45.44−$44,304307,972Direct
Sep 25, 2024Class A Common StockMOption exerciseAcquired+900$2.90+$2,610308,872Direct
Sep 25, 2024Class A Common StockSSaleDisposed−900$46.79−$42,111307,972Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 25, 2024Class A Common StockMOption exerciseDisposed−15,625$0.00$0811,712Direct
Sep 25, 2024Class A Common StockMOption exerciseDisposed−1,875$0.00$0809,837Direct
Sep 25, 2024Class A Common StockMOption exerciseDisposed−1,875$0.00$0807,962Direct
Sep 25, 2024Class A Common StockMOption exerciseDisposed−1,875$0.00$0806,087Direct
Sep 25, 2024Class A Common StockMOption exerciseDisposed−1,875$0.00$0804,212Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)